A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #282

Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?

Ogórek K, Nowak K, Wadych E, et al. Molecules (Basel, Switzerland). 2025.
Weak / noneReviewMentions: GHK-Cu

Editor's note

This is a methodological review, and its value lies precisely in exposing a knowledge gap rather than claiming an effect. It examines whether we are even equipped to measure how well GHK-Cu - encapsulated in liposomes - permeates the skin. The framing is honest: GHK-Cu is credited with beneficial cosmetic properties (reducing fine lines, improving elasticity), but it is a fairly water-loving molecule that struggles to cross the skin's oily outer barrier, and liposome encapsulation is a proposed way to improve delivery. The review's conclusion is that the transport of liposome-encapsulated GHK-Cu has received little study, and it calls for better methods to assess it. For readers weighing GHK-Cu's topical case, this is a clarifying reminder that a central assumption - that the peptide actually reaches its site of action in the skin - remains under-measured. No efficacy or clinical outcomes are reported here; it is a review about measurement readiness, useful mainly for calibrating how much we do not yet know.

Plain-language abstract

Many active ingredients in cosmetics struggle to reach the deeper layers of the skin, which limits how well they work. One such ingredient is GHK-Cu, a copper-containing peptide naturally found in the body that is credited with benefits like softening fine lines and wrinkles and improving skin firmness and elasticity. The problem is that GHK-Cu dissolves easily in water, so it does not readily pass through the skin's oily outer barrier. One proposed solution is to package GHK-Cu inside liposomes - tiny fatty bubbles - to help it penetrate better. This review examined the methods scientists use to study how ingredients, including liposome-packaged GHK-Cu, move across the skin barrier. Its main finding was that very little research has actually measured how well liposome-encapsulated GHK-Cu penetrates the skin, revealing a gap in knowledge. The authors call for better testing methods to answer this question. This review did not test whether GHK-Cu works or measure any health outcome; it focused on whether we currently have the tools to assess whether the peptide even reaches its target in the skin.